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Background. In blood vessels, the endothelium is a crucial signal transduction interface in control of vascular tone and blood
pressure to ensure energy and oxygen supply according to the organs’ needs. In response to vasoactive factors and to shear
stress elicited by blood flow, the endothelium secretes vasodilating or vasocontracting autacoids, which adjust the contractile
state of the smooth muscle. In endothelial sensing of shear stress, the osmo- and mechanosensitive Ca
2+-permeable TRPV4
channel has been proposed to be candidate mechanosensor. Using TRPV4
2/2 mice, we now investigated whether the absence
of endothelial TRPV4 alters shear-stress-induced arterial vasodilation. Methodology/Principal Findings. In TRPV4
2/2 mice,
loss of the TRPV4 protein was confirmed by Western blot, immunohistochemistry and by in situ-patch–clamp techniques in
carotid artery endothelial cells (CAEC). Endothelium-dependent vasodilation was determined by pressure myography in
carotid arteries (CA) from TRPV4
2/2 mice and wild-type littermates (WT). In WT CAEC, TRPV4 currents could be elicited by
TRPV4 activators 4a-phorbol-12,13-didecanoate (4aPDD), arachidonic acid (AA), and by hypotonic cell swelling (HTS). In
striking contrast, in TRPV4
2/2 mice, 4aPDD did not produce currents and currents elicited by AA and HTS were significantly
reduced. 4aPDD caused a robust and endothelium-dependent vasodilation in WT mice, again conspicuously absent in TRPV4
2/
2 mice. Shear stress-induced vasodilation could readily be evoked in WT, but was completely eliminated in TRPV4
2/2 mice. In
addition, flow/reperfusion-induced vasodilation was significantly reduced in TRPV4
2/2 vs. WT mice. Vasodilation in response
to acetylcholine, vasoconstriction in response to phenylephrine, and passive mechanical compliance did not differ between
genotypes, greatly underscoring the specificity of the above trpv4-dependent phenotype for physiologically relevant shear
stress. Conclusions/Significance. Genetically encoded loss-of-function of trpv4 results in a loss of shear stress-induced
vasodilation, a response pattern critically dependent on endothelial TRPV4 expression. Thus, Ca
2+-influx through endothelial
TRPV4 channels is a molecular mechanism contributing significantly to endothelial mechanotransduction.
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TRPV4 Expression. PLoS ONE 2(9): e827. doi:10.1371/journal.pone.0000827
INTRODUCTION
In vascular physiology, Ca
2+-influx in response to mechanical or
agonist stimulation plays a pivotal role in a variety of endothelial
functions, in particular in the Ca
2+-dependent synthesis of
endothelium-derived vasodilating factors such as diffusible nitric
oxide [1] and prostacyclin [2], as well as the endothelium-derived
hyperpolarizing factor (EDHF). EDHF-mediated vasodilation
represents a considerable proportion of total vasodilation, which
is resistant to inhibitors of nitric oxide- and prostacyclin synthesis,
and is caused by endothelium-dependent hyperpolarization of
smooth muscle and subsequent closure of voltage-gated Ca
2+-
channels leading to relaxation [3–5]. Ca
2+-permeable cation
channels of the transient receptor gene super-family (TRP) [6–
13] have been proposed to function as Ca
2+ entry pathway in
response to stimulation of G-protein-coupled receptors, as well as
to mechanical stimulation by increased flow or shear stress [7,14–
16]. Recent studies have provided pharmacological and molecular
biological evidence that Ca
2+-entry mediated by the endothelial
TRP vanilloid type 4 channel (TRPV4) is involved in the synthesis
of nitric oxide [17] and in EDHF signaling [18–20]. TRPV4
channels [16,21–26] can be polymodally activated by osmotic
stress [21,23,26], shear stress [16,17,27], moderate warmth
(.27uC) [28,29], arachidonic acid (AA) and its metabolite 5,6
epoxyeicosatrienoic acid (5,6 EET) [18,19], possibly by low pH
[30], and pharmacologically by the non-PKC-activating phorbol
ester, 4a-phorbol-12,13-didecanoate (4aPDD) [21]. trpv4 gene-
targeted mice exhibit a subtle phenotype with deficits in the
regulation of systemic tonicity by the central nervous system
[24,31], altered transduction of noxious stimuli [24,25,32–34],
and, amongst other phenotypes, defects in the lung alveolar
barrier [35] and in renal tubular K
+ secretion [36].
We recently presented pharmacological evidence that endothe-
lial TRPV4 may function in signal transduction in response to flow
or shear stress [17]. To further analyze TRPV4-mediated
mechanisms in vascular endothelial function in a more definitive
manner, we now tested shear stress and agonist-induced
endothelium-dependent vasodilation in mice lacking the TRPV4
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TRPV4
-/2 mice that (1) these vessels do not relax in response to
4aPDD, (2) shear stress-induced vasodilation is fully eliminated,
and (3) flow-induced vasodilation is greatly attenuated, whereas
agonist-induced vasodilation and constriction were intact. In
summary, our data provide support for an essential role of TRPV4
in the response of arterial endothelia to shear stress.
METHODS
TRPV4
2/2 mice, carotid artery preparation, and
carotid artery endothelial cells.
Genotyping of TRPV4
2/2 mice [24] was performed by poly-
merase chain reaction (PCR) of genomic tail DNA. Primers:
Forward primer (binds to Exon 11): CGCTTCCTGCTTG-
TGTACCT; Reverse primer 1 (binds to Exon 13): GGAGTGC-
CATCTGAGCTCTT. Product size: WT, ,3.6 kb; TRPV4
2/2,
,2.0 kb; Reverse primer 2 (binds to Exon 12): CGATGGT-
GAGCTTGAAGAGG. Product size: WT, ,1.7 kb; TRPV4
2/2,
no signal.
To confirm the lack of the TRPV4 protein, we performed
immunohistochemistry in carotid arteries (CA) of TRPV4
2/2 and
wild-type mice. Animals were fixed by transcardiac perfusion with
10 % neutral-buffered formalin, post-fixed by overnight immer-
sion in the same fixative, and infused with sucrose. Frozen blocks
were sectioned at 12 mm, mounted and immunolabeled using
a TRPV4 C-term specific antibody raised in rabbits against
a synthetic peptide encompassing positions 855 to 873 of mouse
TRPV4 (CDGHQQGYPRKWRTDDAPL), as described pre-
viously [24]. Secondary detection was accomplished using a goat
anti-rabbit antibody, conjugated to Alexafluor 594 (Invitrogen-
Molecular Probes, Carlsbad, CA, USA). Labeled sections of CA
were imaged and photographed using an Olympus BX60 upright
microscope, RFP filter set, a Roper Coolsnap high-res digital
camera, using ISEE image processing software (ISEE, Raleigh,
NC, USA).
Western blotting: Experiments were performed using an
affinity-purified, polyclonal anti-TRPV4 antibody. The antibody
was directed against the synthetic peptide from position 853 to 868
(CDGHQQGYAPKWRTDD) of TRPV4 [37]. In brief, frozen
kidneys from each genotype were ground under nitrogen and
subsequently homogenized in 50 mM Tris, 1 mM EDTA, 2 mM
DTT, 0.2 mM benzamidine, 50 mM leupeptin, 0.5 mM PMSF,
0.1 mg/ml trpysin inhibitor pH 8.0 (homogenization buffer).
Debris and nuclear material were removed by centrifugation at
10006g for 2 min. Membrane proteins were collected by centri-
fugation at 20,0006g for 45 min, resuspended in homogenization
buffer, quantified using the Bio-Rad Protein Assay. 20 mgo f
membrane proteins were separated by sodium dodecylsulfate–
polyacrylamide gel electrophoresis (SDS-PAGE), and electropho-
retically transferred to nitrocellulose membranes (Trans-Blot, all
from Bio-Rad, Munich, Germany). TRPV4 protein was visualized
by an anti-TRPV4 antibody [37], a peroxidase-conjugated anti-
rabbit antiserum (GE Healthcare europe, Freiburg, Germany) and
ECL advance Western blot detection system (GE Healthcare).
Equal loading of proteins was validated by incubation of the
Western blot with an anti-tubulin antibody (Labvision, Fremont,
CA).
Electrophysiology
For patch clamp experiments in carotid artery endothelial cells
(CAEC) [17], freshly isolated segments of the right and left carotid
artery (CA) from female and male TRPV4
2/2 mice and WT
littermates were mounted on a glass capillary with the endothe-
lium facing the bath solution and incubated with 0.05% trypsin
and 0.02% ethylenediaminetetraacetic acid (EDTA) in phosphate
buffered saline (PBS) without Ca
2+/Mg
2+ for up to 10 min, and
then washed. For whole-cell patch-clamp experiments, the patch
pipette was approached to the luminal surface and a single CAEC
was fixed at the tip of the patch pipette by applying a negative
pressure (25 mmHg) to the pipette. After formation of a giga-V
seal, the cell was carefully detached from the luminal face of the
vessel. To achieve electrical access to the cytosol, a negative
pressure (,250 mmHg) was applied to the pipette leading to
rupture of the membrane patch within the tip. Whole-cell mem-
brane currents in CAEC were recorded with an EPC-9 (HEKA)
patch-clamp amplifier using voltage ramps (duration: 1000 ms)
from 2100 to +100 mV as described previously [17]. Initial ohmic
leak currents up to 500 pS were subtracted by using the leak
correction mode of the EPC9. Cells exhibiting larger leak currents
or becoming unstable over time were not further considered. Patch
pipettes had tip resistances of 2–4 MV in symmetrical KCl
solutions. If not otherwise stated, the standard pipette solution was
composed of (in mmol/L): 20 CsCl, 100 cesium methane
sulfonate, 1 MgCl2,4N a 2ATP, 10 EGTA, 0.9 CaCl2, 10 HEPES,
pH adjusted to 7.2 with CsOH; calculated free [Ca
2+] was
0.04 mmol/L. The standard NaCl bath solution contained
(mmol/L): 137 NaCl, 4.5 Na2HPO4, 3 KCl, 1.5 KH2PO4, 0.4
MgCl2, 10 glucose, and 1 CaCl2 (pH 7.4). In experiments
employing hypotonic stress, isotonic and hypotonic bath solutions
consisted of (mmol/L): 90 NaCl, 1 CaCl2, 1 MgCl2,10 glucose, 10
HEPES, pH 7.4. The isotonic solution contained additionally
95 mmol/L mannitol. All experiments were performed at RT.
Data analysis was performed as described previously [38].
Pressure myography
Pressure myography in CA was performed as described previously
[17]. Bath and perfusion solutions contained (in mmol/L): 145
NaCl, 1.2 NaH2PO4, 4.7 KCl, 1.2 MgSO4, 2 CaCl2, 5 glucose, 2
pyruvate, and 3 MOPS buffer (pH 7.4 at 37uC). CA were
mounted on glass capillaries, pressurized to 80 mmHg and were
stretched to their in vivo length. Initially, CA were continuously
perfused at a flow rate of 30 ml/min elicited by a pressure gradient
of 1 mmHg between inflow and outflow glass capillaries of equal
dimensions. After an equilibration period of 30 min, CAs were
pre-constricted with 1 mmol/L phenylephrine (PE) in the bath
solution, if not stated otherwise. After development of stable tone,
intravascular flow was re-established from almost static conditions
(,30 ml/min) to physiologically relevant levels (600 ml/min) by
increasing the pressure gradient between inflow and outflow
capillaries to 20 mmHg. The shear stress increased from ,0.1 to
3 dyne/cm
2. The mean intraluminal pressure remains constant at
80 mmHg under these conditions. To measure sole shear stress-
mediated vasodilation (without increasing flow rate), the viscosity
of the perfusion medium was increased from 0.7 to 2.9 mPa*s by
adding 5% dextran which enhanced shear stress in CA from ,3t o
7 dyne/cm
2. Shear stress was mathematically estimated according
to the Hagen-Poiseuille law: t=4gQ/pr
3; t=shear stress;
g=viscosity; Q=flow, and r=radius. In other sets of experiments,
CAs were perfused with 4aPDD (1 mmol/L), or acetylcholine
(ACh, 1 nmol/L–10 mmol/L) in the presence and absence of the
NO-synthase-inhibitor N
G-nitro-L-arginine (L-NNA, 300 mmol/
L) and the cyclooxygenase inhibitor indomethacin (INDO,
10 mmol/L). To study the dependence of 4aPPD-, shear stress-,
as well as flow/reperfusion-induced vasodilation on endothelial
intracellular Ca
2+-signaling, the endothelium was preloaded with
the Ca
2+-chelator 1,2-bis-(o-aminophenoxy)ethane-N,N,N9,N9-
tetraacetic acid tetra-(acetoxy-methyl) ester (BAPTA-AM,
TRPV4 and Endothelial Function
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stimulation. In another subset of experiments, the endothelium
was pre-incubated with the PLA2 inhibitor 1,1,1-trifluoromethyl-
6,9,12,15-heieicosatetraen-2-one (AACOCF3,3 mmol/L) for
10 min. Diameter changes were expressed as a percentage of the
maximal dilatation induced by 10 mmol/L sodium nitroprusside
(SNP). Maximal constriction was elicited by 60 mmol/L K
+.
Elasticity of CA was tested by increasing the intraluminal pressure
in 20 mmHg steps to up to 140 mmHg in the presence of the
NO-donor SNP. Chemicals were obtained from Sigma-Aldrich
(Mu ¨nchen, Germany).
Statistical analysis
Data are given as mean6SEM. The unpaired Students t-Test was
used to assess differences between groups. P-values of ,0.05 were
considered significant.
RESULTS AND DISCUSSION
Loss of cationic currents in response to 4aPDD,
arachidonic acid and hypotonicity in carotid artery
endothelial cells from TRPV4
2/2 mice
Expression of the TRPV4 protein was evident in the carotid
endothelium and in kidney extracts of WT but not of TRPV4
2/2
mice as determined by immunohistochemistry and Western blot
analysis, respectively (Fig. 1).
In whole cell-patch clamp experiments, 4aPDD (1 mmol/L),
a synthetic activator of TRPV4, gated moderately outward-
rectifying currents in CAEC from WT mice (Fig. 2A left, E).
Ruthenium red (RuR, 1 mmol/L, n=7), a blocker of TRPV
channels, reduced inward currents to 1063% of the initial value,
in a voltage-dependent fashion. 4aPDD-inducible currents were
absent in CAEC from TRPV4
2/2 mice (Fig. 2A, right panel, E).
Arachidonic acid (AA, 10 mmol/L) produced TRPV4 currents in
CAEC of WT littermates, which were reduced by 4065% by
1 mmol/L RuR (n=5; Fig. 2B, left panel; E). In CAEC from
TRPV4
2/2 mice, AA generated significantly smaller currents
(Fig. 2B; right panel, E). Hypo-osmotic stress (HTS; 206 mosmol/
L bath solution, leading to cell swelling and thus stretching of the
plasma membrane) activated TRPV4-currents in CAEC of WT
littermates (Fig. 2C, left panel). These currents were reduced to
3565% of the initial value by RuR (n=6; Fig. 2D, left panel). The
remaining RuR-insensitive current was further reduced to 1064%
by 10 mmol/L Gd
3+ (n=4), an unspecific inorganic blocker of
mechanosensitive channels and a variety of other TRP channels
[6]. HTS-induced currents were also observed in CAEC of
TRPV4
2/2 mice (Fig. 2C, right panel), but the amplitude of these
currents was significantly reduced compared to those in CAEC
from WT animals (Fig. 2E). This smaller HTS-inducible current in
CAEC from TRPV4
2/2 mice was insensitive to RuR, but could
be decreased by 7065% by 10 mmol/L Gd
3+ (n=5; Fig. 2D, right
panel), thus indicating that these currents are carried by other
channels.
In aggregate, these electrophysiological properties of TRPV4
currents in CAEC of WT mice resemble the characteristics of
endothelial TRPV4 from rat carotid artery [17] and mouse aorta
[18]. The complete loss of 4aPDD-induced currents in CAEC
from TRPV4
2/2 mice demonstrates the functional expression of
TRPV4 in carotid endothelia and also implies that 4aPDD
appears to be capable of selectively activating TRPV4 in WT cells.
The severely diminished HTS- and AA-induced currents in CAEC
from TRPV4
2/2 mice show that indeed the majority of these
currents in WT are carried by endothelial TRPV4. Similar
findings were obtained from mouse aortic endothelial cells [18]
derived from another TRPV4
2/2 strain [30], in which TRPV4-
activating stimuli such as 4aPDD, AA, AA-metabolites (EETs) and
HTS did not produce TRPV4-like currents and TRPV4-
associated Ca
2+-responses [18]. In extension of these findings,
we show here that a small residual AA and HTS-inducible cation
current, insensitive to RuR but sensitive to Gd
3+, points to a minor
contribution of other yet unidentified AA-sensitive cationic
channels and/or HTS-sensitive mechanosensitive channels. In
keeping with the RuR-insensitivity of such currents, it appears
likely that the deficiency of TRPV4 is not compensated by other
closely related members of the TRPV subfamily, such as TRPV1
and TRPV2, which do not seem to be expressed in normal carotid
endothelia [17]. In carotid endothelium of either TRPV4
+/+ or
TRPV4
2/2 mice, TRPV1 does not seem to be considerably
expressed and, likewise, the TRPV1 opener capsaicin (1 mmol/L)
did not produce endothelium-dependent vasodilation (data not
shown). Recently, it has been reported that a member of the two-
pore K
+ family of channels, TREK-1 [39,40], bears a functional
resemblance to TRPV4 and could, thus, be a candidate to
substitute for the loss of TRPV4. TREK-1 functions were similar
in CAEC of both genotypes (unpublished observation by our
group). Thus, these observations further support the idea that loss
of TRPV4 is not compensated by other TRPV or TREK
channels.
Figure 1. Immunohistochemistry for TRPV4 in CAs (upper panel) and
Western blot analysis of TRPV4 protein expression in kidneys (lower
panel) of WT and TRPV4
2/2 mice. Note the absence of specific staining
in CA of TRPV4
2/2 mice. Me=media; Lu=lumen; En=endothelium. In
a kidney extract obtained from WT mice, the anti-TRPV4 antibody
detected a protein of ,95 kDa, which is in good agreement with the
calculated molecular weight (98 kDa). Furthermore, an additional band
of ,107 kDa, presumably representing the glycosylated protein, is
detected by the antibody. In extracts from TRPV4
2/2 mice, no signals
were present. Equal protein loading of the blots was validated by
visualization of tubulin.
doi:10.1371/journal.pone.0000827.g001
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2/2 mice. A, left panel,
Representative recording of 4aPDD (1 mmol/L)-inducible TRPV4-currents in CAEC of WT. Voltage-dependent inhibition by RuR (1 mmol/L). Right panel,
4aPDD-inducible currents were undetectable in CAEC of TRPV4
2/2 mice. B, left panel, Representative recording of AA (10 mmol/L)-inducible TRPV4
currents in CAEC of WT and inhibition by RuR (1 mmol/L). Right panel, small AA-inducible cation-currents in CAEC of TRPV4
2/2 mice. C, left panel, HTS
(206 mosmol/L)-inducible TRPV4-currents in CAEC of WT. Right panel, HTS-inducible cation currents of smaller amplitude in CAEC of TRPV4
2/2 mice.
D, left panel, Partial voltage-dependent inhibition of HTS-inducible TRPV4 currents in CAEC of WT and almost complete inhibition by the combination
of RuR and Gd
3+ (10 mmol/L). Right panel, RuR insensitivity and Gd
3+ sensitivity of HTS-inducible cation currents in CAEC of TRPV4
2/2 mice. E, Mean
4aPDD-, AA-, and HTS-inducible TRPV4 and other cation currents in CAEC of WT and TRPV4
2/2 mice. Numbers in brackets indicate the number of
cells investigated. Values are given as means6SEM; * P,0.05, ** P,0.01, t test.
doi:10.1371/journal.pone.0000827.g002
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2/2 mice
To evaluate the functional role of TRPV4 in the endothelium, we
performed pressure myograph experiments in CA from WT and
TRPV4
2/2 mice. In the presence or absence of NO- and cyclo-
oxygenase inhibitors (L-NNA and INDO), the basal (passive)
diameter of CA (pressurized to 80 mmHg) from TRPV4
2/2 mice
and WT littermates did not differ (Fig. 3A and B). The constriction
in response to either phenylephrine (PE, 1 mmol/L and below)
(Fig. 3A, B, and C) or to 60 mmol/L K
+ (Fig. 3A and B) in
TRPV4
2/2 and WT mice was not statistically different. The
vasodilation elicited by sodium nitro prusside (SNP, 10 mmol/L)
was similar in both groups (Fig. 3A and B), which thus suggests
that TRPV4 deficiency does not compromise endothelium-
independent relaxation of smooth muscle. In addition,
TRPV4
2/2 CA and WT CA exhibited a similar passive increase
in CA diameter in response to increasing intravascular pressure
(range 0–140 mmHg) and in the presence of SNP (to eliminate any
myogenic constriction (Bayliss effect) (Fig. 3D). These results
indicate that total vascular compliance, elasticity and response to
static mechanical pressure from within the lumen of the CA are
unaffected by TRPV4 deficiency.
Loss of 4aPDD-induced vasodilation in TRPV4
2/2
mice
Intraluminal application of 4aPDD (1 mmol/L) caused a robust
vasodilation of CA (,60%) in WT mice (Fig. 4A) which was
completely absent if 4aPDD was applied together with the TRPV-
blocker RuR (1 mmol/L, data not shown). In addition, we tested
whether 4aPDD causes EDHF-type vasodilation of WT CA.
EDHF-mediated vasodilation is defined as the vasodilation caused
by endothelium-dependent hyperpolarization of smooth muscle,
which is resistant to inhibitors of NO-synthase and cyclooxygen-
ase. In the presence of both inhibitors, 4aPDD-induced vasodi-
lation was reduced to ,40% of the value obtained without such
inhibitors (Fig. 4A). This results indicates that pharmacological
activation of endothelial TRPV4 leads to vasodilation, which is
partly caused by an EDHF-type signaling in mouse CA (Fig. 4A),
and this is similar to what we observed previously in small arteries
Figure 3. Compliance of carotid arteries (CA) of WT and TRPV4
2/2 mice. A and B, Diameter of CA pressurized to 80 mmHg (basal) and in the
extravascular presence of PE, K
+, and SNP in the absence and presence of L-NNA (300 mmol/L) and INDO (10 mmol/L); WT CA, -L-NNA/INDO: n=11
and+L-NNA/INDO: n=8; TRPV4
2/2 CA, -L-NNA/INDO: n=7 and+L-NNA/INDO: n=8. C, PE-induced contraction of CA from WT (CA, n=4) and TRPV4
2/
2 mice (CA, n=4) in the presence of L-NNA and INDO. D, Change in passive diameter (normalized to body weight) of CA from WT (CA, n=13) and
TRPV4
2/2 mice (CA, n=10) in response to increasing intravascular pressure and in the presence of SNP. Values are given as means6SEM.
doi:10.1371/journal.pone.0000827.g003
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response was more pronounced in the murine CA than in the
rat CA, in which overall EDHF-signaling is weaker than in murine
CA [17,41,42].
In murine CA, this 4aPDD-induced EDHF-type vasodilator
response was almost abolished by inhibition of endothelial SKCa
and IKCa channels, the underlying effectors of the EDHF signal in
these arteries [41], with UCL 1684 (1 mmol/L) [43] and TRAM-
34 (1 mmol/L) [44] (Figure S1). Moreover, this EDHF-type
response, as well as the NO/PGI2-dependent component, was
eliminated after preloading the endothelium with the Ca
2+-
chelator BAPTA-AM to eliminate endothelial Ca
2+ signaling
(Figure S1). This clearly shows that activation of TRPV4 by
application of 4aPDD induces vasodilation which critically depends
on an increase of intracellular Ca
2+ within the endothelium.
In striking difference to the WT, a vasodilator-response to
4aPDD could not be observed in TRPV4
2/2 mice, neither in the
absence nor in the presence of NO- and cyclooxygenase inhibitors
(Fig. 4A). This strongly suggests that 4aPDD-induced vasodilation
in WT mice is mediated by TRPV4, and, in view of the robust
amplitude of this vasodilator response, that TRPV4 plays a central
role in endothelium-dependent regulation of vascular tone.
Total acetylcholine-induced vasodilation and EDHF-
mediated vasodilation is intact in TRPV4
2/2 mice
Total acetylcholine-induced vasodilation (in the absence of NO-
synthase and cyclooxygenase inhibitors) was unchanged in
TRPV4
2/2 mice vs. WT (Fig. 4B). This was also true for
EDHF-mediated vasodilation (Fig. 4C). These data show that
TRPV4 is not appreciably involved in acetylcholine-induced and
either NO or EDHF-mediated vasodilation. Thus, TRPV4 does
not play a role in endothelial agonist-induced and G-protein-
coupled receptor-operated Ca
2+ mobilization and -entry in this
conduit artery.
Loss of shear stress-induced vasodilation in
TRPV4
2/2 mice
The reported mechanosensitivity of TRPV4 channels
[14,16,25,27,34,45,46] and the sensitivity of shear stress-induced
vasodilation of rat CA and gracilis artery [17] to the TRPV
blocker RuR indicate a possible role for TRPV4 in endothelial
mechanotransduction.
To compare shear stress-mediated vasodilation between
TRPV4
2/2 mice and WT littermates, the viscosity of the
perfusion medium was increased by addition of 5% dextran,
resulting in a physiologically relevant increase in shear stress from
,3 to 7 dyn/cm
2. In WT mice, the increase in viscosity elicited
a vasodilation of ,20% in the absence of NO- and cyclooxygenase
inhibitors (Fig. 5A). Inhibition of cyclooxygenases did not reduce
this response suggesting that prostacyclin production does not
contribute to this vasodilator response (data not shown). In the
presence of both inhibitors, the increase in shear stress resulted in
a diminished vasodilation of ,10%, exclusively mediated by the
EDHF system (Fig. 5A). This EDHF-type vasodilator response was
almost abolished by inhibition of endothelial SKCa and IKCa
channels (Figure S2). Buffering of endothelial Ca
2+ greatly
attenuated both the EDHF response alone, as well as the
composite NO/EDHF response (Figure S2), a similar effect to
that on 4aPDD responses. Like shear stress-induced vasodilation
in small and large arteries of the rat [17], murine CA vasodilation
was blocked by the TRPV inhibitor RuR or by pre-incubation
with 3 mmol/L AACOCF3 (Figure S2) to prevent the release of
AA and production of AA metabolites, the putative endogenous
activators of TRPV4 [18,19]. This dependency on PLA2 activity -
also shown by others recently [20] - possibly implies that products
of PLA2 can enhance the mechanotransductory function of
TRPV4. Alternatively, TRPV4 channels may not function directly
Figure 4. 4aPDD and ACh-induced vasodilation in CA of WT and
TRPV4
2/2 mice. A, 4aPDD (1 mmol/L)-induced vasodilation in CA of WT
and TRPV4
2/2 mice in the absence and presence of L-NNA and INDO. WT
CA, -L-NNA/INDO: n=12 and+L-NNA/INDO: n=9; TRPV4
2/2 CA, -L-NNA/
INDO: n=6 and+L-NNA/INDO: n=8. B, ACh-induced vasodilation in CA of
WT (n=7) and TRPV4
2/2 (n=6) in the absence of L-NNA and INDO and B,
in their presence; WT CA (n=6); TRPV4
2/2 CA (n=6). * P,0.001, t test.
doi:10.1371/journal.pone.0000827.g004
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stream signaling (reviewed in Liedtke and Kim 2005).
Strikingly, in TRPV4
2/2 mice, the dextran-mediated increase
in shear stress did not cause any NO or EDHF-mediated
vasodilation, but rather resulted in a subtle, yet appreciable
vasoconstriction (Fig. 5A). This complete loss of shear stress-
induced vasodilation in TRPV4
-/2 mice demonstrates that Ca
2+-
entry through TRPV4 is a crucial step in endothelial mechan-
otransduction in response to shear stress, not compensated by any
other gene in the absence of TRPV4.
In the present study, we go on to demonstrate that CA of
TRPV4
2/2 mice exhibit an altered vasodilation in response to
re-establishing flow through the vessel (reperfusion) from almost
static conditions (30 ml/ml) to physiologically relevant levels
(600 ml/ml), when compared to WT littermates. In general,
flow-evoked vasodilation is a complex Ca
2+-dependent (as well as
possibly Ca
2+-independent), NO- and EDHF-mediated and
strictly endothelium-dependent process [47–49], which in these
respects is remarkably similar to shear-stress induced vasodilation.
In WT mice, the onset of flow, as happens in reperfusion, caused
vasodilation of ,30% in the absence of NO- and cyclooxygenase
inhibitors (Fig. 5B). Similar to shear stress-induced vasodilator
responses, this flow/reperfusion-evoked vasodilation was on
average reduced to ,10% in the presence NO and cyclooxygen-
ase inhibitors (Fig. 5B), thus indicating a partial contribution of the
EDHF system. Consequently, dual inhibition of endothelial SKCa
and IKCa channels eliminated this EDHF response (Figure S3).
Inhibition of cyclooxygenases alone did not diminish this response
suggesting that prostacyclin production does not add further to this
flow/reperfusion-induced vasodilation in the murine carotid artery
(data not shown). Again, like for shear stress and 4aPDD
responses, buffering of endothelial Ca
2+ virtually eliminated the
EDHF response alone and greatly reduced the composite NO/
EDHF response (Figure S3). Moreover, inhibition of PLA2 by
AACOCF3 abolished flow/reperfusion-induced and NO/EDHF-
mediated vasodilation (Figure S3), thus indicating that the release
of AA and generation of AA metabolites, possibly functioning as
(direct or indirect) endogenous modulators of TRPV4, are also
important in this type of vasodilation.
In CA of TRPV4
2/2 mice vs. WT, flow/reperfusion resulted in
a significantly reduced vasodilation of ,15% and ,5% in the
absence and presence of NO and cyclooxygenase inhibitors,
respectively (Fig. 5B). Therefore, these data suggest that TRPV4
also participates critically in flow/reperfusion-induced vasodila-
tion, which, however, in contrast to shear stress-induced
vasodilation, is not completely dependent on TRPV4 and may
involve other Ca
2+-dependent or possibly Ca
2+-independent
mechanisms [49].
In conclusion, we used genetically engineered TRPV4
2/2 mice
to demonstrate the absolute dependence of vasodilation in
response to physiologically relevant shear stress on endothelial
TRPV4 and a significant contribution of TRPV4 to flow/
reperfusion-induced vasodilation. These novel findings are based
on the following facts: (1) The TRPV4-activator 4aPDD dilated
WT CAs, a response-pattern completely absent in TRPV4
2/2. (2)
Shear stress-induced vasodilation was also completely absent in
TRPV4
2/2 mice. (3) Flow/reperfusion-induced vasodilation was
greatly diminished in TRPV4
2/2 mice. In contrast, smooth-
muscle dependent SNP-mediated vasodilation and acetylcholine-
induced vasodilation did not differ between TRPV4
2/2 and WT
mice, reiterating the specificity of our findings (1–3). Based on our
observations, a novel concept emanates, namely that mechanical
activation of TRPV4 in arteries by physiologically relevant shear
stress and flow/reperfusion is a critical component of endothelial
mechanotransduction.
On a final note, this novel role of TRPV4 not only advances our
basic understanding of vascular physiology, it also renders TRPV4
an appealing target [50,51] for therapeutic manipulation of
arterial diameter, e.g. in cardiovascular disease states like
hypertension [52], ischemia-reperfusion-induced vascular injury,
and, last but not least, in atherosclerosis, where chronic mechani-
cal shear stress and inappropriate endothelial Ca
2+ influx have
been suggested to be pathogenic for regional lesion development
and progression (e.g. at the carotid bifurcation). For atheroscle-
rosis, it is tempting to speculate that the inflammatory component
of the process sensitizes endothelial TRPV4 via cytokine-
mechanisms [25]. At least as attractive, and not mutually exclusive
is the hypothesis that arterial injury, like in early atherosclerosis,
will up-regulate endothelial expression of proteinase-activated-
receptor 2 [53], which will be activated proteolytically within the
Figure 5. Shear stress- and flow/reperfusion-induced vasodilation in
CA of WT and TRPV4
2/2 mice. A, Shear stress-induced vasodilation in
CA of WT and TRPV4
2/2 mice in the absence and presence of L-NNA
and INDO; WT CA, n=12 and n=9; TRPV4
2/2 CA, n=6 and n=8,
respectively. Shear stress-induced vasodilation was elicited by switching
to a perfusion medium containing 5% dextran (5% Dex). B, Flow/
reperfusion-induced vasodilation of CA of WT and TRPV4
2/2 mice in the
absence and presence of L-NNA and INDO. WT CA, n=9 and n=8;
TRPV4
2/2 CA, n=7 and n=7, respectively. * P,0.05, ** P,0.01, t test.
doi:10.1371/journal.pone.0000827.g005
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sensitize endothelial TRPV4 channels to respond to mechanical
stress [34].
SUPPORTING INFORMATION
Figure S1 Pharmacological properties of 4aPDD-induced vaso-
dilation in murine CA. From left to right: Inhibition of EDHF-type
responses (in the presence of L-NNA and INDO) by the
combination of IK
Ca/SK
Ca-blockers (TRAM-34 (1 mmol/L) and
UCL 1684 (1 mmol/L); n=4) and after preloading the endothe-
lium with BAPTA-AM (10 mmol/L; n=6) for 10 min to buffer
intracellular Ca
2+. Inhibition of composite NO/EDHF-type
responses (in the absence of L-NNA and INDO) by BAPTA-AM
(n=4). For controls (ctrl, white bars), values6SEM are given in
figure 4. * P,0.05, t test.
Found at: doi:10.1371/journal.pone.0000827.s001 (0.12 MB TIF)
Figure S2 Pharmacological properties of shear stress-induced
vasodilation in murine CA. From left to right: Inhibition of shear
stress (Dex 5%)-induced EDHF-type responses by IK
Ca/SK
Ca
blockers (n=11), after buffering of endothelial intracellular Ca
2+
with BAPTA-AM (n=7). Inhibition of composite NO/EDHF-
type responses by BAPTA-AM (n=8), the TRPV4 blocker RuR
(1 mmol/L; n=4), and by the PLA
2 inhibitor AACOCF
3 (3 mmol/
L; n=4). For controls (ctrl, white bars), values6SEM are given in
figure 5 A. * P,0.05, t test.
Found at: doi:10.1371/journal.pone.0000827.s002 (0.10 MB TIF)
Figure S3 Pharmacological properties of flow/reperfusion-in-
duced vasodilation in murine CA. From left to right: Inhibition of
EDHF-type responses by IK
Ca/SK
Ca blockers (n=5), after
buffering of endothelial intracellular Ca
2+ with BAPTA-AM
(n=3). Inhibition of composite NO/EDHF-type responses by
BAPTA-AM (n=7), and by the PLA
2 inhibitor AACOCF
3 (n=8).
For controls (ctrl, white bars), values6SEM are given in figure 5 B.
*P ,0.05, t test.
Found at: doi:10.1371/journal.pone.0000827.s003 (0.12 MB TIF)
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